INTRODUCTION: Abdominal aortic aneurysm (AAA) is associated with hypercoagulability, evidenced by increased markers of coagulation activation, including thrombin-antithrombin complex (TAT), prothrombin fragments 1 and 2 (F1+2), and D-dimer. Our aim was to compare the effect of endovascular aneurysm repair (EVAR) and open aneurysm repair (OAR) on changes in coagulation activation markers after intervention. METHODS: Consecutive patients with AAAs reaching their intervention threshold in a tertiary vascular referral unit in the United Kingdom were invited to participate. The coagulation markers TAT, F1+2, and D-dimer were measured in venous blood collected at baseline and at 5 months after intervention. A forward stepwise multiple linear regression model was used to identify whether treatment by OAR or EVAR had an effect on changes in coagulation factors, independent of significant covariates. RESULTS: The study included 47 patients (14 EVAR, 33 OAR; 85% men) who were a median age of 76 years (range, 69.5-80 years). Aortic diameter at intervention was 5.9 cm (range, 5.5-6.8 cm). There were no significant differences in clinical, anthropometric, or hematologic parameters between groups. At baseline, TAT (P = .13), F1+2 (P = .08), and D-dimer (P = .11) were similar in EVAR and OAR patients. Postintervention, there was a significant increase in TAT (3.0 [2.1-6.0] vs 7.2 [6.3-8.4] ng/mL; P = .03), F1+2 (242 [189-323] vs 392 [312-494] ng/mL; P = .003), and D-dimer (457 [336-615] vs 1197 [840-1509] ng/mL; P = .002) in the EVAR group. No significant changes were observed after intervention in the OAR group. CONCLUSIONS: AAA-related hypercoagulability persists after intervention, with increased TAT, F1+2, and D-dimer levels after EVAR. These findings suggest a potential period of increased cardiovascular risk in the postoperative period after EVAR.
INTRODUCTION:Abdominal aortic aneurysm (AAA) is associated with hypercoagulability, evidenced by increased markers of coagulation activation, including thrombin-antithrombin complex (TAT), prothrombin fragments 1 and 2 (F1+2), and D-dimer. Our aim was to compare the effect of endovascular aneurysm repair (EVAR) and open aneurysm repair (OAR) on changes in coagulation activation markers after intervention. METHODS: Consecutive patients with AAAs reaching their intervention threshold in a tertiary vascular referral unit in the United Kingdom were invited to participate. The coagulation markers TAT, F1+2, and D-dimer were measured in venous blood collected at baseline and at 5 months after intervention. A forward stepwise multiple linear regression model was used to identify whether treatment by OAR or EVAR had an effect on changes in coagulation factors, independent of significant covariates. RESULTS: The study included 47 patients (14 EVAR, 33 OAR; 85% men) who were a median age of 76 years (range, 69.5-80 years). Aortic diameter at intervention was 5.9 cm (range, 5.5-6.8 cm). There were no significant differences in clinical, anthropometric, or hematologic parameters between groups. At baseline, TAT (P = .13), F1+2 (P = .08), and D-dimer (P = .11) were similar in EVAR and OAR patients. Postintervention, there was a significant increase in TAT (3.0 [2.1-6.0] vs 7.2 [6.3-8.4] ng/mL; P = .03), F1+2 (242 [189-323] vs 392 [312-494] ng/mL; P = .003), and D-dimer (457 [336-615] vs 1197 [840-1509] ng/mL; P = .002) in the EVAR group. No significant changes were observed after intervention in the OAR group. CONCLUSIONS: AAA-related hypercoagulability persists after intervention, with increased TAT, F1+2, and D-dimer levels after EVAR. These findings suggest a potential period of increased cardiovascular risk in the postoperative period after EVAR.
Authors: Ryan M Jamiolkowski; Sa Do Kang; AnnMarie K Rodriguez; Justin M Haseltine; Lauren J Galinat; Alexandra E Jantzen; Tim A Carlon; Marcus D Darrabie; Antonio J Arciniegas; Jose G Mantilla; N Rebecca Haley; Maria Noviani; Jason D Allen; Thomas V Stabler; James W Frederiksen; Oscar Alzate; Lukas G Keil; Siyao Liu; Fu-Hsiung Lin; George A Truskey; Hardean E Achneck Journal: Regen Med Date: 2015-05 Impact factor: 3.806
Authors: Marc A Bailey; Paul D Baxter; Tao Jiang; Aimee M Charnell; Kathryn J Griffin; Anne B Johnson; Katherine I Bridge; Soroush Sohrabi; D Julian A Scott Journal: Aorta (Stamford) Date: 2013-12-01
Authors: Aleksandra Piechota-Polanczyk; Alicja Jozkowicz; Witold Nowak; Wolf Eilenberg; Christoph Neumayer; Tadeusz Malinski; Ihor Huk; Christine Brostjan Journal: Front Cardiovasc Med Date: 2015-05-26
Authors: Katherine Bridge; Charlotte Revill; Fraser Macrae; Marc Bailey; Nadira Yuldasheva; Stephen Wheatcroft; Roger Butlin; Richard Foster; D Julian Scott; Ann Gils; Robert Ariens Journal: PLoS One Date: 2017-05-04 Impact factor: 3.240
Authors: R Lee; K Bellamkonda; A Jones; N Killough; F Woodgate; M Williams; I Cassimjee; A Handa Journal: Eur J Vasc Endovasc Surg Date: 2017-04-14 Impact factor: 7.069
Authors: Keith Allen-Redpath; Maceler Aldrovandi; Sarah N Lauder; Anastasia Gketsopoulou; Victoria J Tyrrell; David A Slatter; Robert Andrews; W John Watkins; Georgia Atkinson; Eileen McNeill; Anna Gilfedder; Majd Protty; James Burston; Sam R C Johnson; Patricia R S Rodrigues; Dylan O Jones; Regent Lee; Ashok Handa; Keith Channon; Samya Obaji; Jorge Alvarez-Jarreta; Gerhard Krönke; Jochen Ackermann; P Vince Jenkins; Peter W Collins; Valerie B O'Donnell Journal: Proc Natl Acad Sci U S A Date: 2019-04-03 Impact factor: 11.205